Nigerian Community Pharmacists Urge Federal Government to Adopt 'Pharmacy First' Ebola Protocol
The Association of Community Pharmacists of Nigeria (ACPN) has called on President Bola Tinubu and state governors to involve community pharmacists in epidemic containment efforts following confirmed Ebola cases.
In Brief
- •The Association of Community Pharmacists of Nigeria (ACPN) has called on President Bola Tinubu and state governors to involve community pharmacists in epidemic containment efforts following confirmed Ebola cases.
- •ACPN National Chairman Ambrose Ezeh urged the government to establish a nationwide 'Pharmacy First' protocol to position pharmacies as frontline centers for early detection and surveillance.
- •The initiative proposes expanding pharmacy roles to include basic screening, health education, early symptom recognition, and prompt patient referrals.
- •The association stated its national network is prepared to activate the screening framework within 48 hours if an enabling policy directive is issued.
Why It Matters
Involving community pharmacies in national disease surveillance could significantly enhance Nigeria's early detection capabilities during infectious disease outbreaks. Because community pharmacies serve as accessible primary contact points for many citizens, integrating them into epidemic response plans could improve case identification and accelerate health system referrals.
Key Details
- Proposed Protocol
- Pharmacy First Initiative
- Implementation Readiness
- Within 48 hours of official directive
- Key Organization
- Association of Community Pharmacists of Nigeria (ACPN)
- Target Disease Focus
- Ebola and other infectious diseases
Original Reporting & Sources
VNews is an independent briefing product. Original reporting remains credited to the following publishers:
This brief was synthesized automatically using attributed third-party reporting. VNews is a digital news publication produced under the VContent Group brand and operated by Francis Vincent Sunday in Ghana, independent from the publishers cited above. Read our AI Transparency Policy and Editorial & Corrections Policy.